Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer
Breast Cancer
About this trial
This is an interventional treatment trial for Breast Cancer focused on measuring stage I breast cancer, stage II breast cancer
Eligibility Criteria
DISEASE CHARACTERISTICS: Diagnosis of stage I or II invasive breast cancer by triple assessment: Clinically Mammogram and/or ultrasound Fine needle cytology Resectable disease by either wide local excision or mastectomy with axillary dissection No ductal carcinoma in situ Hormone receptor status: Not specified PATIENT CHARACTERISTICS: Age: 18 and over Sex: Female Menopausal status: Not specified Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified Other: Not pregnant No known allergy to vital blue dye No mental illness or handicap that would preclude study entry No other severe illness that would preclude study participation PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: Not specified Endocrine therapy: Not specified Radiotherapy: Not specified Surgery: See Disease Characteristics
Sites / Locations
- St. George's Hospital
- Royal Marsden NHS Trust
- Royal Brompton National, Heart and Lung Hospital
- Royal Marsden Hospital